Clinical Trials Logo

Hyperkinesis clinical trials

View clinical trials related to Hyperkinesis.

Filter by:

NCT ID: NCT06064032 Not yet recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder

Cognitive Behavioral Therapy And Motor Learning Technique Among Attention Deficit Hyperactivity Disorder Adults

ADHD
Start date: October 2, 2023
Phase: N/A
Study type: Interventional

The aim of our study to compare the effect of cognitive behavioral therapy and motor learning techniques in adults with Attention Deficit Hyperactivity Disorder. and help the adults to address and revise cognitive distortions and habits affecting your productivity and emotional mindset.participant allocated to control group will be asked to perform cognitive behavioural therapy and participants allocated to experimental group will be asked to perform motor learning activities and cognitive behavioral therapy.

NCT ID: NCT06042257 Not yet recruiting - Clinical trials for Impulsivity in Children With Down Syndrome

Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)

HYP01
Start date: May 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine efficacy of guanfacine immediate release (GIR) for the treatment of hyperactivity/impulsivity and inattention in children 6-12 years of age with Down syndrome (DS) after 8 weeks of treatment.

NCT ID: NCT05957055 Not yet recruiting - Clinical trials for Diabetes Mellitus, Type 1

Lisdexamphetamine vs Methylphenidate for Pediatric Patients With ADHD and Type 1 Diabetes

LAMAinDiab
Start date: January 1, 2024
Phase: Phase 2
Study type: Interventional

This clinical trial aims to evaluate the safety and effectiveness of an intervention involving parental training in behaviour management and medication in children with both Type 1 Diabetes (T1D) and Attention Deficit Disorder with Hyperactivity (ADHD). ADHD is a neurodevelopmental disorder that affects around 5% of school-age children and adolescents, while T1D is a chronic disease requiring strict management. After initial parental training provided for parents/legal guardians, the children will be randomized to one of two cross-over groups, and treated with either lisdexamfetamine or methylphenidate first. After dose optimization for first 5-7 weeks, patients will be treated for 6 months total, after which they will be switched to the other drug. Researchers will then compare the ADHD symptom severity as measured by Conners 3 questionnaire, and compare the frequency of any adverse events associated with the therapy. As secondary outcomes, patient's T1D control and quality of life will be compared between the two drugs.

NCT ID: NCT05897437 Not yet recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder

Motor Performance in Children With Attention Deficit Hyperactivity Disorder

Start date: June 30, 2023
Phase:
Study type: Observational

Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in children. Children with ADHD have difficulties with co-contraction, producing muscle force, and regulating movement velocity, and physical fitness. The purpose of this study was to compare the gross and fine motor abilities in children with ADHD and children with typical development.

NCT ID: NCT05876286 Not yet recruiting - Clinical trials for Attention Deficit Disorder With Hyperactivity

Sleep and Memory Consolidation in Adults With Attention Deficit Hyperactivity.

HYPNOS
Start date: October 15, 2023
Phase: N/A
Study type: Interventional

Attention Deficit Disorder With Hyperactivity is associated with deficits in cognition and sleep. In healthy adults, memory consolidation processes are related to sleep spindle activity in the sleep electroencephalogram. This association is poorly characterized in adults with attention deficit hyperactivity. In this study, the purpose is to characterize sleep microarchitecture disorders through the analysis of different stage of sleep EEG activity during a polysomnographic examination in adult with mixed Attention Deficit Disorder With Hyperactivity presentation compared to healthy.

NCT ID: NCT05568446 Not yet recruiting - Clinical trials for Attention-Deficit/Hyperactivity Disorder

Social VR Based Intervention on Enhancing Social Interaction Skills in Children With AD/HD

Start date: November 15, 2022
Phase: N/A
Study type: Interventional

The study targets children with diagnosed ADHD and aims to (1) develop a social virtual reality based (SocVR) intervention and (2) investigate its effects on improving the social skills and executive functioning of inhibitions, emotional control and attention of the children compared to traditional social skills training. The study will be a three-arm parallel randomised controlled trial comparing the effects of a SocVR with traditional social skills training on social skills and executive functioning of children with ADHD. The study period is 2 months, including 4 weeks (2 sessions per week) of intervention and control, followed by a 4-week follow-up. The participants will be assessed at three time points (i.e. at baseline, 4 weeks and 4 weeks follow-up). The guidelines of Whitehead et al. (2016) suggested that recommended that at least 16 subjects per group for medium effect size in pilot RCT and 15% attrition over time can be expected. Thus, the minimum sample size per group was 20. A total of 60 participants will be recruited in which 20 participants in the social VR group, 20 in the traditional social skills group and 20 in the waitlist control group.

NCT ID: NCT05502536 Not yet recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder

Effects of Fairytales on Preschool Children With Attention Deficit Hyperactivity Disorder

Start date: August 20, 2022
Phase: N/A
Study type: Interventional

Under traditional rehabilitation programs, investigate the additional effects of individualized fairytales on preschool children with Attention Deficit Hyperactivity Disorder with developmental delays.

NCT ID: NCT05468684 Not yet recruiting - Neck Pain Clinical Trials

PROCO Neck: The Course and Neuroplasticity in Neck Pain-Associated Disorders and Whiplash-Associated Disorders

Start date: September 1, 2022
Phase:
Study type: Observational [Patient Registry]

Neck pain-associated disorders (NAD) and whiplash-associated disorders (WAD) are major health problems. NAD has a lifetime prevalence of 54%. Although the majority of patients recovers within the first three months, a minority develops persistent pain. WAD, in contrast, is reported less frequently, but patients are often suffering more badly. Patients with chronic symptoms represent a considerable burden in terms of pain, suffering, health care needs, and social costs. Findings on the natural course of NAD and WAD reflect the necessity to identify factors besides pain related to the persistence of symptoms. First, alterations of input and processing of multiple sensory modalities causing movement control impairment can result in persistent symptoms and affect the quality of life. Besides, findings of psychosocial factors predictive of pain outcomes support the growing body of research proposing a bidirectional relationship between somatic and psychosocial variables. In particular, there is a pressing need to investigate pain-related activity patterns, besides fear-avoidance behavior in NAD and WAD. Maladaptive activity pattern have an impact on on pain and disability in the long-term prognosis. Mt important, given the high prevalence of NAD and WAD, the cortical representation of the cervical spine has not yet been investigated and, reports on neuroplasticity remain scarce. These shortcomings should be addressed to provide evidence for the temporal aspect of neuroplasticity and its involvement in pain persistence. Hypotheses: We hypothesize I. that impaired sensorimotor abilities, mental health at baseline increase pain intensity and disability during measurement. II. that maladaptive pain-related activity patterns avoidance and overactivity at baseline are prognostic factors for pain persistence and disability. III. that the WAD cohort shows more depression, anxiety and stress compared to the NAD cohort.

NCT ID: NCT05070481 Not yet recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder

Prevalence of Disruptive Behavior in Children With Attention Deficit Hyperactivity Disorder(ADHD)

Start date: October 2021
Phase:
Study type: Observational

Identification of prevalence and Risk factors for disruptive behavior in children with Attention Deficit Hyperactivity Disorder and Early recognition of disruptive behavior in children with ADHD

NCT ID: NCT04946877 Not yet recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder

Clinical Study of Comorbidities of Attention Deficit Hyperactivity in Children and Adolescents.

Start date: March 1, 2022
Phase:
Study type: Observational

Determine the frequency of psychiatric and neurological comorbidities in children and adolescence diagnosed with ADHD.